Morphologic and molecular prognostic markers in prostate cancer

被引：29
|
作者：
Ross, JS [1 ]
Sheehan, CE
Dolen, EM
Kallakury, BVS
机构：
[1] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Radiol, Albany, NY 12208 USA
[3] Millennium Pharmaceut Inc, Cambridge, MA USA
[4] Georgetown Univ, Sch Med, Dept Pathol, Georgetown, MD USA
来源：
ADVANCES IN ANATOMIC PATHOLOGY | 2002年 / 9卷 / 02期
关键词：
prostate cancer; biomarker; prognosis; grade; stage; DNA ploidy; cell proliferation; oncogene; cell adhesion; HER-2/neu; apoptosis; proteasome;
D O I：
10.1097/00125480-200203000-00003
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this review, a series of traditional morphology-based measurements, relatively well-documented ancillary biomarkers, and emerging molecular assays are evaluated for their relative ability to predict prognosis in prostate cancer. Prognostic factors that have achieved widespread use and are classified as category I by the College of American Pathologists' Solid Tumor Prognostic Factor Consensus Conference are compared with newer tests that are beginning to be used in clinical practice (category II) and emerging molecular-based assays that have yet to be widely validated in the published literature or in clinical trials (category III).
引用
收藏
页码：115 / 128
页数：14
相关论文
共 50 条
  • [31] Prognostic markers in prostate cancer: Longterm correlation with survival
    Lele, SM
    Giri, DD
    Feldman, JG
    Axiotis, CA
    Kim, YD
    Macchia, RJ
    Pertschuk, LP
    LABORATORY INVESTIGATION, 1997, 76 (01) : 457 - 457
  • [32] Genetic alterations in prostate cancer as diagnostic and prognostic markers
    Saeidi, Hamidreza
    Ismail, Patimah
    Samudi Raju, Chandramathi
    Khairul-Asri, Mohd Ghani
    Bakrin, Ikmal Hisyam
    MALAYSIAN JOURNAL OF PATHOLOGY, 2023, 45 (02) : 149 - 155
  • [33] Prognostic significance of several biomolecular markers in prostate cancer
    Liatkouskaya, A. T.
    Zakharava, A., V
    Cherstvoy, D. E.
    Pashkevich, A. L.
    Sukonko, G. O.
    Rolevich, I. A.
    Masanskiy, L., I
    Sagalchik, M. L.
    Ivanovskaya, I. M.
    Portyanko, S. A.
    VIRCHOWS ARCHIV, 2009, 455 : 138 - 138
  • [34] Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
    Montironi, Rodolfo
    Cimadamore, Alessia
    Lopez-Beltran, Antonio
    Scarpelli, Marina
    Aurilio, Gaetano
    Santoni, Matteo
    Massari, Francesco
    Cheng, Liang
    CELLS, 2020, 9 (05)
  • [35] Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression
    Augustin, H.
    Freibauer, C.
    Bayer, L.
    Lunglmayr, G.
    Tschurlovich, F.
    Kuber, W.
    Pummer, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 279 - 283
  • [36] Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression
    H Augustin
    C Freibauer
    L Bayer
    G Lunglmayr
    F Tschurlovich
    W Kuber
    K Pummer
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 279 - 283
  • [37] Prognostic molecular markers in early breast cancer
    Francisco J Esteva
    Gabriel N Hortobagyi
    Breast Cancer Research, 6
  • [38] Molecular predictive and prognostic markers in colon cancer
    Winder, Thomas
    Lenz, Heinz-Josef
    CANCER TREATMENT REVIEWS, 2010, 36 (07) : 550 - 556
  • [39] Prognostic molecular markers in early breast cancer
    Esteva, FJ
    Hortobagyi, GN
    BREAST CANCER RESEARCH, 2004, 6 (03) : 109 - 118
  • [40] A Panel of Prognostic Molecular Markers in Colorectal Cancer
    Ivanov, K.
    Kolev, N.
    Tonev, A.
    Nikolova, G.
    Softova, E.
    PROCEEDINGS OF THE XXII BIENNIAL CONGRESS OF THE INTERNATIONAL SOCIETY OF UNIVERSITY COLON AND RECTAL SURGEONS - ISUCRS, 2008, : 51 - +
12345